Home Toxicology NAEMSP: EMS role in opioid use disorder
Toxicology
NAEMSP: EMS role in opioid use disorder
The Role of Emergency Medical Services in Addressing Opioid Use Disorder—A Position Statement and Resource Document of NAEMSP
Prehospital Emergency Care · Added 20 May 2026
NAEMSP position statement outlining EMS roles in opioid use disorder treatment, including harm reduction, medication-assisted treatment initiation, and referral pathways.
- Study type
- Guideline / statement
- Design
- Position statement and resource document (NAEMSP)
- Participants
- Not reported
- Main finding
- Recommends scope of practice allowing prehospital buprenorphine, low-barrier MOUD protocols, naloxone distribution/harm reduction, alternate destinations, and anti-stigma education
- Caveat
- US-focused statement, not Australian policy
- Bottom line
- Context only
Learning goal
Understand how paramedics can support harm reduction and opioid use disorder care within Australian practice.
More
- Topic: Toxicology
- Daily scan: 20 May 2026
Related papers on Toxicology
-
SGLT-2 inhibitor hypoglycaemic ketoacidosis
Case report of severe hypoglycaemic ketoacidosis in an SGLT2 inhibitor user requiring insulin — a reminder these agents can produce ketosis with atypical glucose readings that muddle the diabetic-emergencies picture
-
Fatal illicit drug toxicity: mostly polysubstance OHCA
Case series of 46 deaths in Victoria's EDNAV toxicosurveillance registry (2020–2025) — 67% had out-of-hospital cardiac arrest, 91% were polysubstance with mixed stimulant–sedative patterns most common (methamphetamine 54%, heroin 52%), and hypoxic brain injury was the most frequent terminal complication.
-
Paramedic views on prehospital buprenorphine
Abstract not yet available (ahead-of-print). Qualitative case study of paramedic perspectives on prehospital buprenorphine implementation in emergency medical services.
-
IM naloxone better than IN for overdose
Nationwide cohort study compared prehospital outcomes for initial intranasal versus intramuscular naloxone administration in suspected opioid overdose.